Condition
Alzheimer Dementia (AD) clinical trials and research
Research outlook What's coming for Alzheimer's disease: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 20 Alzheimer Dementia (AD) clinical trials that are recruiting, at sites in 10 countries (most in United States (6), China (4), Italy (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 1/2 (2), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 20Clinical trials
- 1New in 30 days
- 10Countries
Newest Alzheimer Dementia (AD) clinical trials
All recruiting trials (20)
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
Restoring Cervical Lymphatic Drainage in Alzheimer’s Disease
A small study tests whether a minimally invasive surgery to improve cervical lymphatic drainage can affect biomarkers, brain imaging, and cognition in people with Alzheimer's who can’t access other disease-modifying therapies.
-
Home-based gamma-tACS with personalized cognitive training for mild Alzheimer's disease
This study tests a home-delivered combination of gamma-frequency tACS and individualized memory training to see if it helps people with mild Alzheimer's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Low-Dose Radiation Therapy to See if It Helps Alzheimer's and Inflammatory Dementias
Researchers will test whether giving small amounts of whole-brain radiation over a short course, then monthly boosts for a year, is tolerable and safe in people over 50 with Alzheimer's or dementia with inflammatory features.
-
Risk-score predictor for dementia in older adults with depression
This study tests whether a point-based risk score from electronic medical records can accurately predict which older adults with depression will develop dementia.
-
IL-2 plus semaglutide in Alzheimer's disease
This study tests a combination of IL-2 and semaglutide to see if it can help people with Alzheimer's disease.
-
BCI with 40Hz Stimulation for Alzheimer’s Disease
This study tests whether a non-invasive brain-computer interface with 40Hz audio-visual stimulation can improve thinking skills in people with Alzheimer’s disease.
-
Lecanemab in Early to Moderate Alzheimer's Disease using Multi-omics data
This study tests whether Lecanemab can help people with early-to-moderate Alzheimer's disease and uses multiple biological data types to understand its effects.
-
Predicting pre-dementia progression in APOE‑ε4 carriers
This project will try a combined genetic, blood, and wearable-monitoring model to see if it can predict which cognitively normal or very mildly impaired adults aged 55+ with an APOE‑ε4 gene will develop biomarker-confirmed MCI within 24 months.
-
Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders
We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.
-
Brain blood flow and sugar transport in Alzheimer's with and without type 2 diabetes
This project will try to see if patterns of brain blood flow and sugar use differ between people with Alzheimer's disease who do and do not have type 2 diabetes and compared with healthy older adults.
-
Online positive psychology program to support thinking and brain health in early memory changes
This study will test whether an online positive psychology program can improve thinking, brain function, and wellbeing in older adults with early memory problems (Subjective Cognitive Decline or Mild Cognitive Impairment).
-
Brain stimulation plus methylphenidate for apathy in Alzheimer's
This trial will test whether combining short sessions of noninvasive brain stimulation (intermittent theta burst) with methylphenidate can reduce apathy in people with Alzheimer's disease or mixed Alzheimer's/vascular dementia.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Intermittent deep brain stimulation of the nucleus basalis to treat Alzheimer's
This will test whether intermittent deep brain stimulation of a small brain region called the nucleus basalis can help sustain or improve thinking and memory in people aged 65–85 with early-stage Alzheimer's disease.
-
Transcranial pulse stimulation to help people with early Alzheimer's disease
We will test whether non-invasive transcranial pulse stimulation can improve thinking, memory, and behavior in people aged 60–90 with early Alzheimer's disease.
-
Investigating genetic factors in patients with neurodegenerative dementia
This study is trying to find out if certain genetic factors are linked to neurodegenerative dementias like Alzheimer's and Lewy Body dementia by looking at blood samples from patients and their family members.
-
Using brain stimulation to improve cognitive control in older adults with mild cognitive impairment
This study is testing if a new type of brain stimulation can help older adults with mild cognitive impairment improve their thinking skills while they play a video game.
-
Genetic factors in early-onset dementia
This study is trying to find out how genetics might affect the risk and progression of early-onset dementia by looking at people with dementia, their families, and healthy individuals.
Related topics
Quick answers
How many Alzheimer Dementia (AD) clinical trials are recruiting right now?
20, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (6 trials), China (4 trials), Italy (2 trials), Canada (2 trials), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.